1. CT‐P10 RAPID INFUSION IN PATIENTS WITH NON‐HODGKIN'S LYMPHOMA OR CHRONIC LYMPHOCYTIC LEUKAEMIA: INTERIM RESULTS FROM A NON‐INTERVENTIONAL POST‐AUTHORISATION SAFETY STUDY. (12th June 2019) Authors: Bishton, M.; Marshall, S.R.; Conteh, V.; Rodríguez Fernández, A.; Kang, H.; Kim, S.; Lee, Y.; Zinzani, P. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 538 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1125: CELESTIMO: A PHASE III TRIAL EVALUATING THE EFFICACY AND SAFETY OF MOSUNETUZUMAB PLUS LENALIDOMIDE VERSUS RITUXIMAB PLUS LENALIDOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA. (23rd June 2022) Authors: Nastoupil, L.; Morschhauser, F.; Scholz, C. W.; Bishton, M.; Yoon, S.-S.; Giri, P.; Wei, M. C.; Knapp, A.; Li, C.-C.; Bottos, A.; Li, H.; Purev, E.; Bartlett, N. L. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1015 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. RESULTS FROM THE SAFETY RUN‐IN PERIOD OF THE SYMPATICO STUDY EVALUATING IBRUTINIB IN COMBINATION WITH VENETOCLAX IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA. (12th June 2019) Authors: Wang, M.; Ramchandren, R.; Chen, R.; Karlin, L.; Chong, G.; Jurczak, W.; Wu, K.; Bishton, M.; Collins, G.; Eliadis, P.; Peyrade, F.; Freise, K.; Sukbuntherng, J.; Lee, Y.; Dobkowska, E.; Fedorov, V.; Neuenburg, J.; Tam, C. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 333 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗